InvestorsHub Logo
Followers 1
Posts 168
Boards Moderated 0
Alias Born 03/06/2014

Re: KraFtaVerK post# 40343

Friday, 02/02/2018 1:11:07 PM

Friday, February 02, 2018 1:11:07 PM

Post# of 54998
This article is very well written. It's obvious that it was done by someone who closely follows the company and knows exactly which buttons to press to drive down the share price in the short term. Well done. I personally believe the author wants to capitalize off the fact that XXII is overbought to drive the share price down heavily to purchase more in advance of the conclusion of the March phase III clinical trial.

The share price will go down in the near term, that is almost certainly a fact. Stop complaining about it. Wait a little while, and if you still believe in XXII, buy more while it's on sale, just don't wait too long or you won't get to profit off of what I predict to be a positive clinical trial result. Anything under 2 is a damn steal if we get there again.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News